Clinical Trial Update: Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety of SI-6603 in patients with lumbar disc herniation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Disc Herniation

Drugs mentioned

• SI-6603

Snippet

Sponsor: Seikagaku Corporation | Conditions: Lumbar Vertebra Hernia | Phase 2 | Status: COMPLETED